Most abundant free AA in plasma and muscle. Primary fuel for enterocytes and lymphocytes (glutaminolysis). Nitrogen shuttle (amide group transfer). Precursor to GABA, glutathione (after hydrolysis to glutamate), and purine/pyrimidine biosynthesis. Conditionally essential in catabolic states (burns, trauma, critical illness).
Half-Life & Elimination Curve (PO: 1h · IV: 1h)
Plasma (PO)t½ Decay (1h)
0×t½0h100%(231 mg/L)
1×t½1h50%(115 mg/L)
2×t½2h25%(57.7 mg/L)
3×t½3h12.5%(28.8 mg/L)
4×t½4h6.3%(14.4 mg/L)
5×t½5h3.1%(7.21 mg/L)
Elimination t½1h (PO)
Rate Constant (ke)0.693 h⁻¹
Time to Peak (Tmax)49m
Est. Peak (Cmax)231 mg/L
Clearance (CL)14.6 L/h
97% Washout (5×t½)5h
Dosing Guidelines
Oral (PO): Typical 10 g (Range: 5–20 g)
Intravenous (IV): Typical 10 g (Range: 5–20 g)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 85% · Volume of Distribution (Vd): 21 L · Absorption (ka): 2 h⁻¹ (t½ka ≈ 21m) [PMID 35032556]
Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 21 L [PMID 35032556]
Pathways It Modulates
Glutaminolysis → TCA anaplerosis (substrate) — pathway substrate — clinical use in critical illness, athletic supplementation, GI integrity